# Effect of Dopaminergic Medication on Recovery of Aphasia

> **NCT00941265** · NA · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 12 (actual)

## Conditions studied

- Aphasia

## Interventions

- **DRUG:** levodopa and benserazide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00941265
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941265, "Effect of Dopaminergic Medication on Recovery of Aphasia". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00941265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*